Otaka, Yasushi
Arakawa, Ryosuke
Narishige, Ryuichiro
Okubo, Yoshiro
Tateno, Amane
Article History
Received: 30 December 2021
Accepted: 17 March 2022
First Online: 29 March 2022
Declarations
:
: Informed consent was not obtained as only anonymized information was used in the data sampling. The research subjects were presented with an explanation of the study objectives, methods and publication of results, and were guaranteed the opportunity to refuse participation. The present study was approved by the Ethics Committee of Nippon Medical School Hospital (B-2020-113) and conforms to the provisions of the Declaration of Helsinki.
: Not applicable.
: Author Yoshiro Okubo has received grants or speaker’s honoraria from Dainippon Sumitomo Pharma, Otsuka, Eli Lilly, Yoshitomi, and Meiji within the past 3 years. Author Ryosuke Arakawa has received speaker’s honoraria from Dainippon Sumitomo Pharma and Pfizer within the past 3 years. The remaining authors declare no conflict of interest.